CG Oncology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	32.49	257.07	8.27	88.14	88.14
Short-Term Investments	709.67	484.93	179.41	55.34	55.34
Cash & Short-Term Investments	742.16	742	187.67	143.48	143.48
Cash Growth	0.02%	295.37%	30.80%	-	-
Accounts Receivable	0.69	-	-	-	-
Other Receivables	-	-	0.09	0.3	0.3
Total Trade Receivables	0.69	-	0.09	0.3	0.3
Inventory	1.57	-	-	-	-
Other Current Assets	15.07	12.21	6.36	3.42	3.42
Total Current Assets	759.48	754.21	194.12	147.21	147.21
Net Property, Plant & Equipment	19.57	0.49	0.49	0.51	0.51
Other Intangible Assets	0.58	-	-	-	-
Goodwill	10.3	-	-	-	-
Other Long-Term Assets	1.68	0.09	4.69	0.03	0.03
Total Assets	791.59	754.8	199.3	147.75	147.75
Accounts Payable	5.71	6.52	3.24	0.99	0.99
Accrued Expenses	24.21	14.67	10.44	5.29	5.29
Current Portion of Long-Term Debt	-	-	-	8.97	8.97
Current Portion of Leases	0.92	0.19	0.22	0.19	0.19
Other Current Liabilities	-	-	0.35	-	-
Total Current Liabilities	30.84	21.37	14.25	15.43	15.43
Long-Term Debt	3	-	-	6.53	6.53
Long-Term Leases	3.11	0.05	0.24	0.26	0.26
Other Long-Term Liabilities	2.05	-	0.01	0.35	0.35
Total Long-Term Liabilities	8.15	0.05	0.26	7.14	7.14
Total Liabilities	38.99	21.42	14.51	22.57	22.57
Additional Paid-in Capital	1,132	951.35	6.84	3.64	3.64
Retained Earnings	-378.98	-217.98	-129.94	-81.34	-81.34
Total Common Shareholders' Equity	752.6	733.38	-123.1	-77.69	-77.69
Minority Interest	-	-	307.89	202.87	82.87
Shareholders' Equity	752.6	733.38	184.79	125.18	5.18
Total Liabilities & Equity	791.59	754.8	199.3	147.75	147.75
Total Debt	7.02	0.24	0.46	15.94	15.94
Net Cash (Debt)	735.13	741.76	187.21	127.54	127.54
Net Cash Growth	-0.89%	296.21%	46.79%	-	-
Net Cash Per Share	9.51	11.87	43.23	34.09	0.04
Book Value	752.6	733.38	-123.1	-77.69	-77.69
Book Value Per Share	9.74	11.73	-28.42	-20.77	-0.02
Tangible Book Value	741.73	733.38	-123.1	-77.69	-77.69
Tangible Book Value Per Share	9.60	11.73	-28.42	-20.77	-0.02

Updated Feb 27, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q